MedPath

广州白云山医药集团股份有限公司白云山制药总厂

Ownership
-
Established
1973-07-01
Employees
-
Market Cap
-
Website
http://www.byszc.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

363

NMPA:363

Drug Approvals

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20254302
Approval Date
May 27, 2025
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20254301
Approval Date
May 27, 2025
NMPA

Sildenafil Citrate Tablets

Product Name
枸橼酸西地那非片
Approval Number
国药准字H20247264
Approval Date
Nov 1, 2024
NMPA

Tabellae Bergenini Compositae

Product Name
复方岩白菜素片
Approval Number
国药准字H44023911
Approval Date
Oct 10, 2024
NMPA

Clozapine Tablets

Product Name
氯氮平片
Approval Number
国药准字H44021433
Approval Date
Oct 10, 2024
NMPA

Pyritinol Hydrochloride Tablets

Product Name
盐酸吡硫醇片
Approval Number
国药准字H44021501
Approval Date
Oct 10, 2024
NMPA

Labetalol Hydrochloride Tablets

Product Name
盐酸拉贝洛尔片
Approval Number
国药准字H44024809
Approval Date
Oct 10, 2024
NMPA

Ketotifen Fumarate Tablets

Product Name
富马酸酮替芬片
Approval Number
国药准字H44020957
Approval Date
Oct 10, 2024
NMPA

Osalmid Tablets

Product Name
柳胺酚片
Approval Number
国药准字H44021486
Approval Date
Oct 10, 2024
NMPA

Levamisole Hydrochloride Tablets

Product Name
盐酸左旋咪唑片
Approval Number
国药准字H44021500
Approval Date
Oct 10, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 37
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.